CEP164 and cystic fibrosis: Filtering for biallelic or compound heterozygous CEP164 variants in the rare disease cohort, we identified an adult patient recruited under “non‐CF bronchiectasis” in whom we identified compound heterozygous stop gain variants in CEP164 (Figure 1A, Figure S1).